Use of a soluble epoxide hydrolase inhibitor as an adjunctive analgesic in a horse with laminitis
- 1 July 2013
- journal article
- case report
- Published by Elsevier in Veterinary Anaesthesia and Analgesia
- Vol. 40 (4) , 440-448
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Environmental Health Sciences (ES02710, P42 ES04699)
This publication has 47 references indexed in Scilit:
- Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociceptionProstaglandins & Other Lipid Mediators, 2011
- Epoxygenated Fatty Acids and Soluble Epoxide Hydrolase Inhibition: Novel Mediators of Pain ReductionJournal of Agricultural and Food Chemistry, 2010
- Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogsEuropean Journal of Pharmaceutical Sciences, 2010
- Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseasesNature Reviews Drug Discovery, 2009
- Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathwaysProceedings of the National Academy of Sciences, 2008
- Orally Bioavailable Potent Soluble Epoxide Hydrolase InhibitorsJournal of Medicinal Chemistry, 2007
- Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs)Prostaglandins & Other Lipid Mediators, 2007
- Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory painLife Sciences, 2006
- Peptidyl-urea based inhibitors of soluble epoxide hydrolasesBioorganic & Medicinal Chemistry Letters, 2006
- Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitorsProceedings of the National Academy of Sciences, 2006